Combined androgen and estrogen receptor status in breast cancer: treatment prediction and prognosis in a population-based prospective cohort
K Elebro, S Borgquist, M Simonsson, A Markkula… - Clinical cancer …, 2015 - AACR
… receptor (AR) expression was prognostic and/or predictive for endocrine treatment alone or
in combination with estrogen receptor … status, and to influence endocrine treatment response. …
in combination with estrogen receptor … status, and to influence endocrine treatment response. …
The estrogen receptor: a model for molecular medicine
EV Jensen, VC Jordan - Clinical cancer research, 2003 - AACR
… treatment schedules of tamoxifen were predicted to be more effective than short-term treatment.
… reactivation of the selective estrogen receptor modulator-estrogen receptor α complex. …
… reactivation of the selective estrogen receptor modulator-estrogen receptor α complex. …
In vivo prediction of response to antiestrogen treatment in estrogen receptor-positive breast cancer
RJ Bennink, G van Tienhoven, LJ Rijks… - Journal of Nuclear …, 2004 - Soc Nuclear Med
… Knowledge of the estrogen receptor (ER) status of breast tumors is of known value to
predict patient prognosis and to determine proper patient management (2–4). Until now, the …
predict patient prognosis and to determine proper patient management (2–4). Until now, the …
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
… routinely used that can predict response to commonly prescribed therapies. The presence
of estrogen receptors is the best indicator of response to anti-estrogen agents such as …
of estrogen receptors is the best indicator of response to anti-estrogen agents such as …
Outcome prediction for estrogen receptor–positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
MJ Ellis, Y Tao, J Luo, R A'hern… - Journal of the …, 2008 - academic.oup.com
… help clinicians make decisions about additional treatment options for patients who have
received neoadjuvant endocrine treatment for estrogen receptor–positive (ER+) breast cancer. …
received neoadjuvant endocrine treatment for estrogen receptor–positive (ER+) breast cancer. …
Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic …
… estrogen receptor according to the administration route of progestins. (c) Subgroup analysis
for estrogen receptor … (d) Overall analysis for progesterone receptor. (e) Subgroup analysis …
for estrogen receptor … (d) Overall analysis for progesterone receptor. (e) Subgroup analysis …
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
J Bostner, E Karlsson, MJ Pandiyan… - … research and treatment, 2013 - Springer
… cancer, partly through regulation of estrogen receptor α (ER) activity. Reliable biomarkers
for treatment prediction are required for improved individualized treatment. We performed a …
for treatment prediction are required for improved individualized treatment. We performed a …
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer …
VJ Bardou, G Arpino, RM Elledge… - Journal of clinical …, 2003 - ascopubs.org
… as a predictor of response to endocrine treatment in … to predict response. In the 1970s, it
was first hypothesized that PgR might provide additional information to more accurately predict …
was first hypothesized that PgR might provide additional information to more accurately predict …
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
… treat-all strategy and a treat-none strategy, respectively. The clinical applicability of a risk
prediction … ’s net benefit curve is above the treat-all and treat-none strategies, ie the area formed …
prediction … ’s net benefit curve is above the treat-all and treat-none strategies, ie the area formed …
Integration of clinical variables for the prediction of late distant recurrence in patients with estrogen receptor–positive breast cancer treated with 5 years of endocrine …
… Women with estrogen receptor (ER) –positive primary breast … have indicated that extending
treatment beyond 5 years can … previously reported a clinical treatment score that integrates …
treatment beyond 5 years can … previously reported a clinical treatment score that integrates …
相关搜索
- outcome prediction estrogen receptor status
- breast cancer estrogen receptor
- adjuvant endocrine therapy estrogen receptor status
- progesterone and estrogen receptors conservative treatment
- selective estrogen receptor modulation
- estrogen receptor probe
- imaging of estrogen receptors
- early stage estrogen receptor
- influence of estrogen receptor status
- estrogen receptor function
- target for the treatment estrogen receptor
- molecular biology of the estrogen receptor
- postmenopausal patients with estrogen receptor
- estrogen receptor modulation reduction in risk
- low estrogen receptor neoadjuvant systemic chemotherapy
- 17α iodovinyl estrogen receptor status